Not listed
GH19-1933 THE SANRU TUSIMAME PROJECT WILL PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM IN 7 HEALTH ZONES OF HAUT KATANGA PROVINCE. - DEMOCRATIC REPUBLIC OF CONGO (DRC) IS EXPERIENCING A GENERALIZED HIV / AIDS EPIDEMIC, WITH THE PREVALENCE OF INFECTION IN THE GENERAL POPULATION ESTIMATED AT 1.2% (DHS 2013-2014). IN HAUT KATANGA PROVINCE, LIKE THE REST OF THE COUNTRY, HIV IS PREDOMINANTLY TRANSMITTED THROUGH HETEROSEXUAL SEX AND INCREASINGLY AMONG THE KEY POPULATIONS (KPS); AND IT IS DRIVEN BY BEHAVIORAL DETERMINANTS AS WELL AS PERVASIVE GENDER AND SOCIO-ECONOMIC INEQUALITIES. HIV PREVALENCE AMONG ANTENATAL WOMEN IN HAUT KATANGA PROVINCE IS 2.8%. DESPITE MANY EFFORTS AN INVESTMENTS MADE, ONLY FEW HIV INDIVIDUALS ARE IDENTIFIED AND START TREATMENT. EVEN FOR THOSE WHO ARE ON TREATMENT, ONLY LIMITED NUMBERS OF THEM ARE RETAINED IN CARE AFTER A PERIOD OF 12 MONTHS. SANRU IS PLEASED TO SUBMIT A RESPONSE TO REQUEST FOR APPLICATIONS (RFA) NUMBER CDC-RFA-GH19-1933, THE ENHANCE POPULATION ACCESS TO COMPREHENSIVE HIV/AIDS SERVICES IN ORDER TO ACHIEVE HIV/AIDS EPIDEMIC CONTROL IN THE D.R. CONGO, ESPECIALLY IN HAUT KATANGA. SANRU BRINGS SOLID EXPERIENCE IN ENSURING HIV SERVICES IN IMPLEMENTING CLIENT CENTERED, IN THE SELECTED HEALTH ZONES (HZ) OF HAUT KATANGA. THE PROJECT NAME IS TUSIMAME IS A KISWAHILI WORD THAT MEANS "LET US GET UP, STAND ON OUR OWN FEET, AND KEEP OURSELVES UP". THE OVERALL GOAL OF TUSIMAME IS TO PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM TO ACHIEVE HIV EPIDEMIC CONTROL BY 2030 IN SELECTED HZ IN HAUT KATANGA PROVINCE. WORKING OVER 5 YEARS ACROSS ALL 6 HZ, TUSIMAME WILL INCREASE QUALITY HIV TESTING SERVICES (HTS) WITH AN EMPHASIS ON HIGH YIELD ENTRY POINTS AND EXTENSION HTS COVERAGE TOWARDS GEOGRAPHIC AREAS FOR HIGH RISK GROUPS SPECIFICALLY KP AND VULNERABLE POPULATIONS; TO INTEGRATE INNOVATIVE APPROACHES, FOCUSING ON POOR REACH SUB-GROUPS (CHILDREN AND MEN, COMMERCIAL SEX WORKERS) AND TARGETING HIGH RISK PEOPLE USING SCREENING TOOL; TO INTEGRATE HTS WITH CARE FOR ALL HIV+ PATIENTS WITH APPROPRIATE THERAPEUTIC EDUCATION PRIOR TO ART ACCORDING TO 'TEST AND START' APPROACH; TO IMPROVE ART PATIENT RETENTION IN ORDER TO ENSURE VIRAL SUPPRESSION; OFFERING OVC SERVICES TO ELIGIBLE CLIENTS AND HIV SERVICES CARE CONTINUUM; AND TO MAINTAIN QUALITY AT EACH STEP. THE TUSIMAME PROJECT PLANS TO ACHIEVE THE FOLLOWING: 1) 100 % FROM 16% OF NEWLY IDENTIFIED INDIVIDUALS OFFERED PARTNER NOTIFICATION SERVICES (PNS), ACCEPTED PNS, PARTNERS ELICITED, PARTNERS CONTACTED, TESTED, TESTED POSITIVE AND LINKED TO CARE; 2) 95 % FROM 90% OF THE PROPORTION OF INDIVIDUALS NEWLY IDENTIFIED POSITIVE THAT WERE INITIATED ON ART WITHIN 14 DAYS (LINKAGE TO CARE); 3) 100 % FROM 90% OF CLINICAL CARE OF HIV/AIDS AND OPPORTUNISTIC INFECTIONS (OI), INCLUDING TB AND SEXUAL TRANSMITTED INFECTIONS (STI); 4) 95% FROM 84% OF PLHIV INITIATED ON ART AND RETAINED ON ART FOR 12 MONTHS AFTER INITIATION; 5) 95% FROM 74.5% OF PLHIV INITIATED ON ART WHO ARE VIRALLY SUPPRESSED AFTER 6 MONTHS; AND 6) 50% OF PLHIV SCREENED FOR SEXUAL GENDER-BASED VIOLENCE (SGBV), OFFERED CLINICAL SERVICES AND REFERRED TO NON-CLINICAL POST-SGBV SERVICES. SANRU OFFERS TO CDC A COMPARATIVE ADVANTAGE THROUGH: 1) ITS LOW COST OF IMPLEMENTATION OF INTERVENTIONS; 2) ITS VAST NETWORK OF PLHIV SUPPORT GROUPS, WHICH WILL ENSURE LONG-TERM PROJECT SUSTAINABILITY AND CULTURALLY APPROPRIATE INTERVENTIONS; 3) ITS EXISTING RELATIONSHIPS WITH PUBLIC AND PRIVATE HEALTH PROVIDERS ACROSS HAUT KATANGA, WHICH WILL ALLOW PROJECT BENEFICIARIES ACCESS TO HIGH QUALITY SERVICES; 4) ITS LOCALLY SENSITIVE TESTED TOOLS FROM CLINICAL AND SOCIAL SERVICES WHICH WILL ENSURE A CLIENT-CENTERED APPROACH THAT RESONATES WITH PROJECT BENEFICIARIES AND GAINS THEIR BUY-IN TO PROJECT ACTIVITIES, INCLUDING ORPHANS AND VULNERABLE CHILDREN (OVC); AND 5) ITS ABILITY TO ENSURE A RAPID START-UP DUE ITS CURRENT PRESENCE UNDER NOFO NUMBER GH13-1321, AWARDED IN 2013.
$0 9/30/24 Not listed
GH19-1933 THE SANRU TUSIMAME PROJECT WILL PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM IN 7 HEALTH ZONES OF HAUT KATANGA PROVINCE. - DEMOCRATIC REPUBLIC OF CONGO (DRC) IS EXPERIENCING A GENERALIZED HIV / AIDS EPIDEMIC, WITH THE PREVALENCE OF INFECTION IN THE GENERAL POPULATION ESTIMATED AT 1.2% (DHS 2013-2014). IN HAUT KATANGA PROVINCE, LIKE THE REST OF THE COUNTRY, HIV IS PREDOMINANTLY TRANSMITTED THROUGH HETEROSEXUAL SEX AND INCREASINGLY AMONG THE KEY POPULATIONS (KPS); AND IT IS DRIVEN BY BEHAVIORAL DETERMINANTS AS WELL AS PERVASIVE GENDER AND SOCIO-ECONOMIC INEQUALITIES. HIV PREVALENCE AMONG ANTENATAL WOMEN IN HAUT KATANGA PROVINCE IS 2.8%. DESPITE MANY EFFORTS AN INVESTMENTS MADE, ONLY FEW HIV INDIVIDUALS ARE IDENTIFIED AND START TREATMENT. EVEN FOR THOSE WHO ARE ON TREATMENT, ONLY LIMITED NUMBERS OF THEM ARE RETAINED IN CARE AFTER A PERIOD OF 12 MONTHS. SANRU IS PLEASED TO SUBMIT A RESPONSE TO REQUEST FOR APPLICATIONS (RFA) NUMBER CDC-RFA-GH19-1933, THE ENHANCE POPULATION ACCESS TO COMPREHENSIVE HIV/AIDS SERVICES IN ORDER TO ACHIEVE HIV/AIDS EPIDEMIC CONTROL IN THE D.R. CONGO, ESPECIALLY IN HAUT KATANGA. SANRU BRINGS SOLID EXPERIENCE IN ENSURING HIV SERVICES IN IMPLEMENTING CLIENT CENTERED, IN THE SELECTED HEALTH ZONES (HZ) OF HAUT KATANGA. THE PROJECT NAME IS TUSIMAME IS A KISWAHILI WORD THAT MEANS "LET US GET UP, STAND ON OUR OWN FEET, AND KEEP OURSELVES UP". THE OVERALL GOAL OF TUSIMAME IS TO PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM TO ACHIEVE HIV EPIDEMIC CONTROL BY 2030 IN SELECTED HZ IN HAUT KATANGA PROVINCE. WORKING OVER 5 YEARS ACROSS ALL 6 HZ, TUSIMAME WILL INCREASE QUALITY HIV TESTING SERVICES (HTS) WITH AN EMPHASIS ON HIGH YIELD ENTRY POINTS AND EXTENSION HTS COVERAGE TOWARDS GEOGRAPHIC AREAS FOR HIGH RISK GROUPS SPECIFICALLY KP AND VULNERABLE POPULATIONS; TO INTEGRATE INNOVATIVE APPROACHES, FOCUSING ON POOR REACH SUB-GROUPS (CHILDREN AND MEN, COMMERCIAL SEX WORKERS) AND TARGETING HIGH RISK PEOPLE USING SCREENING TOOL; TO INTEGRATE HTS WITH CARE FOR ALL HIV+ PATIENTS WITH APPROPRIATE THERAPEUTIC EDUCATION PRIOR TO ART ACCORDING TO 'TEST AND START' APPROACH; TO IMPROVE ART PATIENT RETENTION IN ORDER TO ENSURE VIRAL SUPPRESSION; OFFERING OVC SERVICES TO ELIGIBLE CLIENTS AND HIV SERVICES CARE CONTINUUM; AND TO MAINTAIN QUALITY AT EACH STEP. THE TUSIMAME PROJECT PLANS TO ACHIEVE THE FOLLOWING: 1) 100 % FROM 16% OF NEWLY IDENTIFIED INDIVIDUALS OFFERED PARTNER NOTIFICATION SERVICES (PNS), ACCEPTED PNS, PARTNERS ELICITED, PARTNERS CONTACTED, TESTED, TESTED POSITIVE AND LINKED TO CARE; 2) 95 % FROM 90% OF THE PROPORTION OF INDIVIDUALS NEWLY IDENTIFIED POSITIVE THAT WERE INITIATED ON ART WITHIN 14 DAYS (LINKAGE TO CARE); 3) 100 % FROM 90% OF CLINICAL CARE OF HIV/AIDS AND OPPORTUNISTIC INFECTIONS (OI), INCLUDING TB AND SEXUAL TRANSMITTED INFECTIONS (STI); 4) 95% FROM 84% OF PLHIV INITIATED ON ART AND RETAINED ON ART FOR 12 MONTHS AFTER INITIATION; 5) 95% FROM 74.5% OF PLHIV INITIATED ON ART WHO ARE VIRALLY SUPPRESSED AFTER 6 MONTHS; AND 6) 50% OF PLHIV SCREENED FOR SEXUAL GENDER-BASED VIOLENCE (SGBV), OFFERED CLINICAL SERVICES AND REFERRED TO NON-CLINICAL POST-SGBV SERVICES. SANRU OFFERS TO CDC A COMPARATIVE ADVANTAGE THROUGH: 1) ITS LOW COST OF IMPLEMENTATION OF INTERVENTIONS; 2) ITS VAST NETWORK OF PLHIV SUPPORT GROUPS, WHICH WILL ENSURE LONG-TERM PROJECT SUSTAINABILITY AND CULTURALLY APPROPRIATE INTERVENTIONS; 3) ITS EXISTING RELATIONSHIPS WITH PUBLIC AND PRIVATE HEALTH PROVIDERS ACROSS HAUT KATANGA, WHICH WILL ALLOW PROJECT BENEFICIARIES ACCESS TO HIGH QUALITY SERVICES; 4) ITS LOCALLY SENSITIVE TESTED TOOLS FROM CLINICAL AND SOCIAL SERVICES WHICH WILL ENSURE A CLIENT-CENTERED APPROACH THAT RESONATES WITH PROJECT BENEFICIARIES AND GAINS THEIR BUY-IN TO PROJECT ACTIVITIES, INCLUDING ORPHANS AND VULNERABLE CHILDREN (OVC); AND 5) ITS ABILITY TO ENSURE A RAPID START-UP DUE ITS CURRENT PRESENCE UNDER NOFO NUMBER GH13-1321, AWARDED IN 2013.
$0 9/25/24 Not listed
GH19-1933 THE SANRU TUSIMAME PROJECT WILL PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM IN 7 HEALTH ZONES OF HAUT KATANGA PROVINCE. - DEMOCRATIC REPUBLIC OF CONGO (DRC) IS EXPERIENCING A GENERALIZED HIV / AIDS EPIDEMIC, WITH THE PREVALENCE OF INFECTION IN THE GENERAL POPULATION ESTIMATED AT 1.2% (DHS 2013-2014). IN HAUT KATANGA PROVINCE, LIKE THE REST OF THE COUNTRY, HIV IS PREDOMINANTLY TRANSMITTED THROUGH HETEROSEXUAL SEX AND INCREASINGLY AMONG THE KEY POPULATIONS (KPS); AND IT IS DRIVEN BY BEHAVIORAL DETERMINANTS AS WELL AS PERVASIVE GENDER AND SOCIO-ECONOMIC INEQUALITIES. HIV PREVALENCE AMONG ANTENATAL WOMEN IN HAUT KATANGA PROVINCE IS 2.8%. DESPITE MANY EFFORTS AN INVESTMENTS MADE, ONLY FEW HIV INDIVIDUALS ARE IDENTIFIED AND START TREATMENT. EVEN FOR THOSE WHO ARE ON TREATMENT, ONLY LIMITED NUMBERS OF THEM ARE RETAINED IN CARE AFTER A PERIOD OF 12 MONTHS. SANRU IS PLEASED TO SUBMIT A RESPONSE TO REQUEST FOR APPLICATIONS (RFA) NUMBER CDC-RFA-GH19-1933, THE ENHANCE POPULATION ACCESS TO COMPREHENSIVE HIV/AIDS SERVICES IN ORDER TO ACHIEVE HIV/AIDS EPIDEMIC CONTROL IN THE D.R. CONGO, ESPECIALLY IN HAUT KATANGA. SANRU BRINGS SOLID EXPERIENCE IN ENSURING HIV SERVICES IN IMPLEMENTING CLIENT CENTERED, IN THE SELECTED HEALTH ZONES (HZ) OF HAUT KATANGA. THE PROJECT NAME IS TUSIMAME IS A KISWAHILI WORD THAT MEANS "LET US GET UP, STAND ON OUR OWN FEET, AND KEEP OURSELVES UP". THE OVERALL GOAL OF TUSIMAME IS TO PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM TO ACHIEVE HIV EPIDEMIC CONTROL BY 2030 IN SELECTED HZ IN HAUT KATANGA PROVINCE. WORKING OVER 5 YEARS ACROSS ALL 6 HZ, TUSIMAME WILL INCREASE QUALITY HIV TESTING SERVICES (HTS) WITH AN EMPHASIS ON HIGH YIELD ENTRY POINTS AND EXTENSION HTS COVERAGE TOWARDS GEOGRAPHIC AREAS FOR HIGH RISK GROUPS SPECIFICALLY KP AND VULNERABLE POPULATIONS; TO INTEGRATE INNOVATIVE APPROACHES, FOCUSING ON POOR REACH SUB-GROUPS (CHILDREN AND MEN, COMMERCIAL SEX WORKERS) AND TARGETING HIGH RISK PEOPLE USING SCREENING TOOL; TO INTEGRATE HTS WITH CARE FOR ALL HIV+ PATIENTS WITH APPROPRIATE THERAPEUTIC EDUCATION PRIOR TO ART ACCORDING TO 'TEST AND START' APPROACH; TO IMPROVE ART PATIENT RETENTION IN ORDER TO ENSURE VIRAL SUPPRESSION; OFFERING OVC SERVICES TO ELIGIBLE CLIENTS AND HIV SERVICES CARE CONTINUUM; AND TO MAINTAIN QUALITY AT EACH STEP. THE TUSIMAME PROJECT PLANS TO ACHIEVE THE FOLLOWING: 1) 100 % FROM 16% OF NEWLY IDENTIFIED INDIVIDUALS OFFERED PARTNER NOTIFICATION SERVICES (PNS), ACCEPTED PNS, PARTNERS ELICITED, PARTNERS CONTACTED, TESTED, TESTED POSITIVE AND LINKED TO CARE; 2) 95 % FROM 90% OF THE PROPORTION OF INDIVIDUALS NEWLY IDENTIFIED POSITIVE THAT WERE INITIATED ON ART WITHIN 14 DAYS (LINKAGE TO CARE); 3) 100 % FROM 90% OF CLINICAL CARE OF HIV/AIDS AND OPPORTUNISTIC INFECTIONS (OI), INCLUDING TB AND SEXUAL TRANSMITTED INFECTIONS (STI); 4) 95% FROM 84% OF PLHIV INITIATED ON ART AND RETAINED ON ART FOR 12 MONTHS AFTER INITIATION; 5) 95% FROM 74.5% OF PLHIV INITIATED ON ART WHO ARE VIRALLY SUPPRESSED AFTER 6 MONTHS; AND 6) 50% OF PLHIV SCREENED FOR SEXUAL GENDER-BASED VIOLENCE (SGBV), OFFERED CLINICAL SERVICES AND REFERRED TO NON-CLINICAL POST-SGBV SERVICES. SANRU OFFERS TO CDC A COMPARATIVE ADVANTAGE THROUGH: 1) ITS LOW COST OF IMPLEMENTATION OF INTERVENTIONS; 2) ITS VAST NETWORK OF PLHIV SUPPORT GROUPS, WHICH WILL ENSURE LONG-TERM PROJECT SUSTAINABILITY AND CULTURALLY APPROPRIATE INTERVENTIONS; 3) ITS EXISTING RELATIONSHIPS WITH PUBLIC AND PRIVATE HEALTH PROVIDERS ACROSS HAUT KATANGA, WHICH WILL ALLOW PROJECT BENEFICIARIES ACCESS TO HIGH QUALITY SERVICES; 4) ITS LOCALLY SENSITIVE TESTED TOOLS FROM CLINICAL AND SOCIAL SERVICES WHICH WILL ENSURE A CLIENT-CENTERED APPROACH THAT RESONATES WITH PROJECT BENEFICIARIES AND GAINS THEIR BUY-IN TO PROJECT ACTIVITIES, INCLUDING ORPHANS AND VULNERABLE CHILDREN (OVC); AND 5) ITS ABILITY TO ENSURE A RAPID START-UP DUE ITS CURRENT PRESENCE UNDER NOFO NUMBER GH13-1321, AWARDED IN 2013.
$0 5/8/24 Not listed
GH19-1933 THE SANRU TUSIMAME PROJECT WILL PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM IN 7 HEALTH ZONES OF HAUT KATANGA PROVINCE. - DEMOCRATIC REPUBLIC OF CONGO (DRC) IS EXPERIENCING A GENERALIZED HIV / AIDS EPIDEMIC, WITH THE PREVALENCE OF INFECTION IN THE GENERAL POPULATION ESTIMATED AT 1.2% (DHS 2013-2014). IN HAUT KATANGA PROVINCE, LIKE THE REST OF THE COUNTRY, HIV IS PREDOMINANTLY TRANSMITTED THROUGH HETEROSEXUAL SEX AND INCREASINGLY AMONG THE KEY POPULATIONS (KPS); AND IT IS DRIVEN BY BEHAVIORAL DETERMINANTS AS WELL AS PERVASIVE GENDER AND SOCIO-ECONOMIC INEQUALITIES. HIV PREVALENCE AMONG ANTENATAL WOMEN IN HAUT KATANGA PROVINCE IS 2.8%. DESPITE MANY EFFORTS AN INVESTMENTS MADE, ONLY FEW HIV INDIVIDUALS ARE IDENTIFIED AND START TREATMENT. EVEN FOR THOSE WHO ARE ON TREATMENT, ONLY LIMITED NUMBERS OF THEM ARE RETAINED IN CARE AFTER A PERIOD OF 12 MONTHS. SANRU IS PLEASED TO SUBMIT A RESPONSE TO REQUEST FOR APPLICATIONS (RFA) NUMBER CDC-RFA-GH19-1933, THE ENHANCE POPULATION ACCESS TO COMPREHENSIVE HIV/AIDS SERVICES IN ORDER TO ACHIEVE HIV/AIDS EPIDEMIC CONTROL IN THE D.R. CONGO, ESPECIALLY IN HAUT KATANGA. SANRU BRINGS SOLID EXPERIENCE IN ENSURING HIV SERVICES IN IMPLEMENTING CLIENT CENTERED, IN THE SELECTED HEALTH ZONES (HZ) OF HAUT KATANGA. THE PROJECT NAME IS TUSIMAME IS A KISWAHILI WORD THAT MEANS "LET US GET UP, STAND ON OUR OWN FEET, AND KEEP OURSELVES UP". THE OVERALL GOAL OF TUSIMAME IS TO PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM TO ACHIEVE HIV EPIDEMIC CONTROL BY 2030 IN SELECTED HZ IN HAUT KATANGA PROVINCE. WORKING OVER 5 YEARS ACROSS ALL 6 HZ, TUSIMAME WILL INCREASE QUALITY HIV TESTING SERVICES (HTS) WITH AN EMPHASIS ON HIGH YIELD ENTRY POINTS AND EXTENSION HTS COVERAGE TOWARDS GEOGRAPHIC AREAS FOR HIGH RISK GROUPS SPECIFICALLY KP AND VULNERABLE POPULATIONS; TO INTEGRATE INNOVATIVE APPROACHES, FOCUSING ON POOR REACH SUB-GROUPS (CHILDREN AND MEN, COMMERCIAL SEX WORKERS) AND TARGETING HIGH RISK PEOPLE USING SCREENING TOOL; TO INTEGRATE HTS WITH CARE FOR ALL HIV+ PATIENTS WITH APPROPRIATE THERAPEUTIC EDUCATION PRIOR TO ART ACCORDING TO 'TEST AND START' APPROACH; TO IMPROVE ART PATIENT RETENTION IN ORDER TO ENSURE VIRAL SUPPRESSION; OFFERING OVC SERVICES TO ELIGIBLE CLIENTS AND HIV SERVICES CARE CONTINUUM; AND TO MAINTAIN QUALITY AT EACH STEP. THE TUSIMAME PROJECT PLANS TO ACHIEVE THE FOLLOWING: 1) 100 % FROM 16% OF NEWLY IDENTIFIED INDIVIDUALS OFFERED PARTNER NOTIFICATION SERVICES (PNS), ACCEPTED PNS, PARTNERS ELICITED, PARTNERS CONTACTED, TESTED, TESTED POSITIVE AND LINKED TO CARE; 2) 95 % FROM 90% OF THE PROPORTION OF INDIVIDUALS NEWLY IDENTIFIED POSITIVE THAT WERE INITIATED ON ART WITHIN 14 DAYS (LINKAGE TO CARE); 3) 100 % FROM 90% OF CLINICAL CARE OF HIV/AIDS AND OPPORTUNISTIC INFECTIONS (OI), INCLUDING TB AND SEXUAL TRANSMITTED INFECTIONS (STI); 4) 95% FROM 84% OF PLHIV INITIATED ON ART AND RETAINED ON ART FOR 12 MONTHS AFTER INITIATION; 5) 95% FROM 74.5% OF PLHIV INITIATED ON ART WHO ARE VIRALLY SUPPRESSED AFTER 6 MONTHS; AND 6) 50% OF PLHIV SCREENED FOR SEXUAL GENDER-BASED VIOLENCE (SGBV), OFFERED CLINICAL SERVICES AND REFERRED TO NON-CLINICAL POST-SGBV SERVICES. SANRU OFFERS TO CDC A COMPARATIVE ADVANTAGE THROUGH: 1) ITS LOW COST OF IMPLEMENTATION OF INTERVENTIONS; 2) ITS VAST NETWORK OF PLHIV SUPPORT GROUPS, WHICH WILL ENSURE LONG-TERM PROJECT SUSTAINABILITY AND CULTURALLY APPROPRIATE INTERVENTIONS; 3) ITS EXISTING RELATIONSHIPS WITH PUBLIC AND PRIVATE HEALTH PROVIDERS ACROSS HAUT KATANGA, WHICH WILL ALLOW PROJECT BENEFICIARIES ACCESS TO HIGH QUALITY SERVICES; 4) ITS LOCALLY SENSITIVE TESTED TOOLS FROM CLINICAL AND SOCIAL SERVICES WHICH WILL ENSURE A CLIENT-CENTERED APPROACH THAT RESONATES WITH PROJECT BENEFICIARIES AND GAINS THEIR BUY-IN TO PROJECT ACTIVITIES, INCLUDING ORPHANS AND VULNERABLE CHILDREN (OVC); AND 5) ITS ABILITY TO ENSURE A RAPID START-UP DUE ITS CURRENT PRESENCE UNDER NOFO NUMBER GH13-1321, AWARDED IN 2013.
$0 5/8/24 Not listed
GH19-1933 THE SANRU TUSIMAME PROJECT WILL PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM IN 7 HEALTH ZONES OF HAUT KATANGA PROVINCE. - DEMOCRATIC REPUBLIC OF CONGO (DRC) IS EXPERIENCING A GENERALIZED HIV / AIDS EPIDEMIC, WITH THE PREVALENCE OF INFECTION IN THE GENERAL POPULATION ESTIMATED AT 1.2% (DHS 2013-2014). IN HAUT KATANGA PROVINCE, LIKE THE REST OF THE COUNTRY, HIV IS PREDOMINANTLY TRANSMITTED THROUGH HETEROSEXUAL SEX AND INCREASINGLY AMONG THE KEY POPULATIONS (KPS); AND IT IS DRIVEN BY BEHAVIORAL DETERMINANTS AS WELL AS PERVASIVE GENDER AND SOCIO-ECONOMIC INEQUALITIES. HIV PREVALENCE AMONG ANTENATAL WOMEN IN HAUT KATANGA PROVINCE IS 2.8%. DESPITE MANY EFFORTS AN INVESTMENTS MADE, ONLY FEW HIV INDIVIDUALS ARE IDENTIFIED AND START TREATMENT. EVEN FOR THOSE WHO ARE ON TREATMENT, ONLY LIMITED NUMBERS OF THEM ARE RETAINED IN CARE AFTER A PERIOD OF 12 MONTHS. SANRU IS PLEASED TO SUBMIT A RESPONSE TO REQUEST FOR APPLICATIONS (RFA) NUMBER CDC-RFA-GH19-1933, THE ENHANCE POPULATION ACCESS TO COMPREHENSIVE HIV/AIDS SERVICES IN ORDER TO ACHIEVE HIV/AIDS EPIDEMIC CONTROL IN THE D.R. CONGO, ESPECIALLY IN HAUT KATANGA. SANRU BRINGS SOLID EXPERIENCE IN ENSURING HIV SERVICES IN IMPLEMENTING CLIENT CENTERED, IN THE SELECTED HEALTH ZONES (HZ) OF HAUT KATANGA. THE PROJECT NAME IS TUSIMAME IS A KISWAHILI WORD THAT MEANS "LET US GET UP, STAND ON OUR OWN FEET, AND KEEP OURSELVES UP". THE OVERALL GOAL OF TUSIMAME IS TO PROVIDE QUALITY COMPREHENSIVE FACILITY-BASED HIV PREVENTION, CARE, AND TREATMENT PROGRAM TO ACHIEVE HIV EPIDEMIC CONTROL BY 2030 IN SELECTED HZ IN HAUT KATANGA PROVINCE. WORKING OVER 5 YEARS ACROSS ALL 6 HZ, TUSIMAME WILL INCREASE QUALITY HIV TESTING SERVICES (HTS) WITH AN EMPHASIS ON HIGH YIELD ENTRY POINTS AND EXTENSION HTS COVERAGE TOWARDS GEOGRAPHIC AREAS FOR HIGH RISK GROUPS SPECIFICALLY KP AND VULNERABLE POPULATIONS; TO INTEGRATE INNOVATIVE APPROACHES, FOCUSING ON POOR REACH SUB-GROUPS (CHILDREN AND MEN, COMMERCIAL SEX WORKERS) AND TARGETING HIGH RISK PEOPLE USING SCREENING TOOL; TO INTEGRATE HTS WITH CARE FOR ALL HIV+ PATIENTS WITH APPROPRIATE THERAPEUTIC EDUCATION PRIOR TO ART ACCORDING TO 'TEST AND START' APPROACH; TO IMPROVE ART PATIENT RETENTION IN ORDER TO ENSURE VIRAL SUPPRESSION; OFFERING OVC SERVICES TO ELIGIBLE CLIENTS AND HIV SERVICES CARE CONTINUUM; AND TO MAINTAIN QUALITY AT EACH STEP. THE TUSIMAME PROJECT PLANS TO ACHIEVE THE FOLLOWING: 1) 100 % FROM 16% OF NEWLY IDENTIFIED INDIVIDUALS OFFERED PARTNER NOTIFICATION SERVICES (PNS), ACCEPTED PNS, PARTNERS ELICITED, PARTNERS CONTACTED, TESTED, TESTED POSITIVE AND LINKED TO CARE; 2) 95 % FROM 90% OF THE PROPORTION OF INDIVIDUALS NEWLY IDENTIFIED POSITIVE THAT WERE INITIATED ON ART WITHIN 14 DAYS (LINKAGE TO CARE); 3) 100 % FROM 90% OF CLINICAL CARE OF HIV/AIDS AND OPPORTUNISTIC INFECTIONS (OI), INCLUDING TB AND SEXUAL TRANSMITTED INFECTIONS (STI); 4) 95% FROM 84% OF PLHIV INITIATED ON ART AND RETAINED ON ART FOR 12 MONTHS AFTER INITIATION; 5) 95% FROM 74.5% OF PLHIV INITIATED ON ART WHO ARE VIRALLY SUPPRESSED AFTER 6 MONTHS; AND 6) 50% OF PLHIV SCREENED FOR SEXUAL GENDER-BASED VIOLENCE (SGBV), OFFERED CLINICAL SERVICES AND REFERRED TO NON-CLINICAL POST-SGBV SERVICES. SANRU OFFERS TO CDC A COMPARATIVE ADVANTAGE THROUGH: 1) ITS LOW COST OF IMPLEMENTATION OF INTERVENTIONS; 2) ITS VAST NETWORK OF PLHIV SUPPORT GROUPS, WHICH WILL ENSURE LONG-TERM PROJECT SUSTAINABILITY AND CULTURALLY APPROPRIATE INTERVENTIONS; 3) ITS EXISTING RELATIONSHIPS WITH PUBLIC AND PRIVATE HEALTH PROVIDERS ACROSS HAUT KATANGA, WHICH WILL ALLOW PROJECT BENEFICIARIES ACCESS TO HIGH QUALITY SERVICES; 4) ITS LOCALLY SENSITIVE TESTED TOOLS FROM CLINICAL AND SOCIAL SERVICES WHICH WILL ENSURE A CLIENT-CENTERED APPROACH THAT RESONATES WITH PROJECT BENEFICIARIES AND GAINS THEIR BUY-IN TO PROJECT ACTIVITIES, INCLUDING ORPHANS AND VULNERABLE CHILDREN (OVC); AND 5) ITS ABILITY TO ENSURE A RAPID START-UP DUE ITS CURRENT PRESENCE UNDER NOFO NUMBER GH13-1321, AWARDED IN 2013.
$1.2m 3/5/24